|
Hello,
As part of our ongoing commitment to share important decisions and recommendations with you, below is a summary of today’s Advisory Committee on Immunization Practices (ACIP) meeting and subsequent vote.
On April 13, the Centers for Disease Control and Prevention (CDC) sent out a message via the Health Alert Network about recent cases of cerebral venous sinus thrombosis with thrombocytopenia in individuals after receiving the Janssen COVID-19 vaccine. CDC recommended that clinicians pause the use of the Janssen COVID-19 vaccine until the ACIP could meet to further review the cases and assess their potential significance. For more information about the cases, please see the CDC Health Alert Network from April 13, 2021.
The ACIP met today, April 14, to hear several presentations about the cases and discuss policy options. After a very thorough conversation, the committee agreed to continue the pause on vaccination with the Janssen COVID-19 vaccine until they could review additional data. The ACIP will meet again in approximately 1 week or 10 days.
Thank you.
|
